Categories Finance, LATEST, U.S. Markets News

Netflix customers will stay loyal despite price hike, finds survey

Gone are those days when people used to bicker over price hikes of products and services, at pubs or gatherings. With higher disposable incomes, the current generation is ready to pay more, if what they get in return is top-class.

Apple had realized this long back – the reason why it has ardent fan following despite each new model coming at a higher price tag. And now, a new survey cements this theory, with Netflix at the epicenter.

Courtesy: Marit & Toomas Hinnosaar, Flickr

According to the survey conducted by Piper Jaffray analyst Michael Olson, Netflix’s international users will stay loyal to the streaming platform even it were to increase its subscription fees. The survey was conducted on Netflix subscribers from seven different international markets. Less than 15% of the subscribers said they would end their subscription if the company increased its fees by 20%.

Netflix’s international users will stay loyal to the streaming platform even it were to increase its subscription fees.

This does not mean customers are insensitive to price change. However, if the company provides excellent service, the customers would remain loyal and would be willing to pay more for the same.

Netflix aims to build a loyal customer base in about 200 countries by spending a hefty amount on programming. In the last three months of 2017, the company reported having close to 6.36 million subscribers in the international markets. It ended the year having 117.58 million subscribers, including 1.98 million US subscribers. The company seen its user base grow last year, despite the price hike it announced in October.

Even if companies like HBO try and match Netflix in terms of subscribers, Netflix will continue to have an upper hand in the streaming battle as it offers more original shows, compared to its rivals.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Tags

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top